Hapvida’s shareholders’ meeting (HAPV3) approved authorization for a capital increase via the issuance of 1 billion new common shares without statutory reform.
The health operator informs that the increase in the authorized capital limit has already been substantially consumed.
The purpose of the vote was to restore the limit of increases already made and does not mean that the company will necessarily exercise it.
According to the minutes of the meeting, there were 5,063,367,643 votes in favor of the proposition, 9,568,926 votes against and 48,070,545 abstentions.
Shareholders also approved other topics, such as reorganizing the number of positions and functions of the board, reducing the minimum number of members from six to five.
THE NAIS IS OFFICIAL EDITOR ON NAIS NEWS